Dexmethylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0781-2727

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dexmethylphenidate Hydrochloride (NDC 0781-2727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mglabel (10mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 10 mg by Sandoz Inc. The label indicates 30 capsules in the package, with storage instructions between 20°C to 25°C, and mentions dispensing in a tight container. It includes a barcode and manufacturer details for Societal CDMO Gainesville, LLC in GA and Sandoz Inc. in NJ.*

FDA Label Image

15mglabel (15mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 15 mg by Sandoz Inc. The label shows 30 capsules with storage instructions at 20 to 25°C and controlled room temperature warnings. It includes a note to dispense with a medication guide and manufacturer information for Societal CDMO Gainesville, LLC and Sandoz Inc.*

FDA Label Image

20mglabel (20mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 20 mg by Sandoz Inc. The label specifies a package of 30 capsules, with storage instructions between 20°C to 25°C and excursions permitted between 15°C and 30°C. It notes to dispense with the Medication Guide and includes manufacturer information for Societal CDMO Gainesville, LLC and Sandoz Inc.*

FDA Label Image

25mglabel (25mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules, 25 mg strength, in a 30 capsule package. The label includes storage instructions, manufacturer information (Sandoz Inc and Societal CDMO Gainesville, LLC), a barcode, and a note to dispense with the medication guide. The dosage form is extended-release capsules for oral use.*

FDA Label Image

30mglabel (30mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 30 mg by Sandoz Inc. The oral capsule bottle contains 30 capsules. The label includes storage instructions, dosage notes, and manufacturer information for Societal CDMO Gainesville, LLC and Sandoz Inc.*

FDA Label Image

35mglabel (35mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 35 mg by Sandoz Inc. The label states it is prescription-only, dispensed with a medication guide, and contains 30 capsules. Storage instructions specify 20°C to 25°C with allowed excursions, and to store in a tight container out of children's reach. Manufactured by Societal CDMO Gainesville, LLC and Sandoz Inc.*

FDA Label Image

40mglabel (40mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 40 mg, oral extended-release capsules, containing 30 capsules per package. Manufactured by Societal CDMO Gainesville, LLC for Sandoz Inc. The label includes storage instructions and notes dispensing with a Medication Guide.*

FDA Label Image

5mglabel (5mglabel)

Label for Dexmethylphenidate Hydrochloride Extended-Release Capsules 5 mg by Sandoz Inc. The label indicates the product contains 30 capsules and includes dosage and storage instructions. It notes the product is prescription-only and directs users to dispense with a medication guide. The label lists manufacturing information and a barcode.*

FDA Label Image

Structure (Image 01)

Chemical structure of dexmethylphenidate hydrochloride, showing its molecular arrangement including a piperidine ring, phenyl ring, and a methyl ester group.*

FDA Label Image

Fig1 (Image 02)

A line graph comparing plasma dexmethylphenidate concentration (ng/mL) over time (hours) after administration of Dexmethylphenidate Hydrochloride Extended-Release Capsules 20 mg and Immediate-Release Tablets 2 x 10 mg. The graph shows concentration peaks and declines for both formulations up to 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.